Ajinomoto (2802) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
1 Sep, 2026Growth strategy and market environment
Focus on ICT sector growth, driven by AI and increasing data volumes, with ABF as a core product.
ABF maintains over 95% market share, leveraging early-stage customer collaboration and high-speed development.
Demand for high-performance substrates is rising due to AI, HPC, and advanced packaging technologies, with logic IC market forecast to grow by 37% in 2026 and 27% in 2027.
Product mix is shifting toward higher value-added ABF, improving profit margins from 30% in FY2018 to over 50% in FY2025.
Expansion into peripheral materials (adhesives, magnetic materials) and next-generation packaging, including co-packaged optics and optical waveguides, to support future growth.
Production capacity and supply chain
Asset-light model: varnish production in-house, other processes outsourced for flexibility and efficiency.
Gunma Plant began operations in 2025, featuring automation and IoT systems, with phased investments to expand capacity through 2030.
New plant planned in Gifu Prefecture to further increase supply capacity beyond 2030, with ¥25 billion investment planned between 2023 and 2030.
Current production can be increased by moving from single-shift to multi-shift operations.
Decentralized and complementary production structure ensures stable supply, risk mitigation, and global support with sites in Japan, China, Taiwan, and the US.
Customer relationships, R&D, and innovation
ABF is custom-developed for each customer, integrating performance and pricing needs through collaborative development.
Early-stage collaboration with end users and substrate manufacturers drives innovation and high-speed development.
R&D and technical teams work closely with customers to anticipate next-generation requirements and address on-site challenges.
Expansion into adhesive, molding, and magnetic materials for advanced semiconductor applications, with magnetic materials already contributing to profit.
Strong global presence with subsidiaries and technical professionals in key markets for real-time customer engagement.
Latest events from Ajinomoto
- Amino acid innovation powers global growth, health, and sustainability, with strong returns.2802
Corporate presentation - Record Q1 sales and profit led to upward full-year guidance amid strong electronic materials demand.2802
Q1 2027 - Marketing and digital transformation drive ambitious 2030 growth, brand, and ESG targets.2802
Investor update - Global leader in amino acid science targets growth, health impact, and major sustainability gains.2802
Investor presentation - Record sales and profit highs, with raised full-year profit outlook and strong segment momentum.2802
Q3 2026 - Doubling medical food sales by 2030 through 20%+ growth, innovation, and global expansion.2802
Investor update - CDMO revenue is set to triple by FY2030 as Forge Biologics drives gene therapy growth.2802
Investor Day 2024 - Sales up 7.7% with record profit, but net profit fell 12% on tax; guidance unchanged.2802
Q1 2025 - Record sales and profit growth led to upward forecasts and increased shareholder returns.2802
Q2 2025